Silymarin nanoformulation as potential anticancer agent in experimental Ehrlich ascites carcinoma-bearing animals

  • Mohamed El-Far, Neven Salah, Alaa Essam, Amira O Abd El-Azim, Ibrahim M El-Sherbiny
  • Nanomedicine, August 2018, Future Medicine
  • DOI: 10.2217/nnm-2017-0394

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Ibrahim M. El-Sherbiny and Mohamed El-Far